Researchers Seek Retraction of MD-18 Celexa Study

Share This Item Feb. 23, 2018 – Los Angeles, California – A group of researchers sent a letter this week to Dr. Robert Freedman, Editor of the American Journal of Psychiatry, calling for the retraction of a Celexa study the researchers claim is rife with “serious misrepresentations.” The study, known as the MD-18 ‘Wagner’ study, was published in the June 2004 issue of the American Journal of Psychiatry. Citing unsealed court documents from Celexa litigation in Massachusetts, the researchers assert that MD-18 should be retracted because the study represents “a serious stain on the reputation of the American Journal of Psychiatry, the American Psychiatric Association, and the profession of academic and clinical psychiatry at large.” The researchers argue the drug manufacturer’s improper conduct with respect to MD-18 speaks to a larger issue of “industry manipulation of clinical trial data.”…

Read more detail on Recent Aviation Law posts –

This entry was posted in Aviation Law and tagged , , , , , . Bookmark the permalink.

Leave a Reply